CreativeOne Wealth LLC Grows Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

CreativeOne Wealth LLC increased its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 89.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,223 shares of the company's stock after buying an additional 12,843 shares during the period. CreativeOne Wealth LLC's holdings in Option Care Health were worth $632,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the stock. Cornerstone Investment Partners LLC increased its position in Option Care Health by 3.6% in the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock worth $221,000 after buying an additional 333 shares in the last quarter. UMB Bank n.a. boosted its stake in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares during the period. Assetmark Inc. increased its position in Option Care Health by 2.0% during the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company's stock valued at $579,000 after acquiring an additional 487 shares during the last quarter. Pacer Advisors Inc. increased its position in Option Care Health by 2.2% during the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock valued at $591,000 after acquiring an additional 537 shares during the last quarter. Finally, Sheets Smith Wealth Management grew its holdings in shares of Option Care Health by 2.4% in the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company's stock worth $553,000 after purchasing an additional 550 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Insider Buying and Selling at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 0.64% of the stock is owned by company insiders.

Option Care Health Stock Performance

Shares of NASDAQ OPCH traded up $0.19 during trading hours on Thursday, reaching $32.30. The stock had a trading volume of 792,013 shares, compared to its average volume of 1,780,185. The firm has a market cap of $5.31 billion, a price-to-earnings ratio of 27.18, a PEG ratio of 2.30 and a beta of 1.07. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The firm has a 50-day moving average of $33.33 and a 200-day moving average of $28.70.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on OPCH. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday. JPMorgan Chase & Co. upped their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, Barrington Research reiterated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research report on Monday. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $33.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.